SOD1‐lowering strategies that reduce SOD1 mRNA and inhibit synthesis of new SOD1 protein have emerged as promising therapeutic approaches for SOD1‐ALS. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.